Insulin receptor substrate 1 (IRS1), protein kinase B (AKT), and ERK are the key components of the insulin signaling pathway; impaired IRS1 signaling leads to decreased activation of AKT and subsequent dysregulation of ERK involved in insulin resistance and metabolic dysfunction (Ding et al., 2019). Here, AKT1 is linked to Insulin resistance.